Riskpilot← Back to searchSign inGet full accessINTER-NOVUS AKTIEBOLAG
ABBankruptOrg 5562687706Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19880 employees
Revenue 2023
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2023
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
INTER-NOVUS AKTIEBOLAG
Org number
5562687706
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 september 1988
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-04-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva konsultverksamhet i affärsutveckling, management, marknadsförings- och exportfrågor. Agentur, export- och importverksamhet och handel dels med bosättnings- och presentartiklar, sport- och fritidsprodukter och dels produkter till hälsovårdssektorn, verkstadsindustrien samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 289 | 278 | — | 55 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −57 | −77 | 0 | 21 | 0 |
| Depreciation & amort. | −0 | −0 | — | −0 | — |
| EBIT | −57 | −77 | 0 | 21 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | −57 | −77 | 0 | 21 | 0 |
| Tax | −0 | −0 | — | −0 | — |
| Net profit | −57 | −77 | — | 21 | — |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 447 | 224 | — | 136 | — |
| Equity | 38 | 101 | — | 104 | — |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 408 | 123 | — | 32 | — |
| Total debt | 408 | 123 | — | 32 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20192023
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NM Liquidator | Liquidator | 2026 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2026 | |
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INTER-NOVUS AKTIEBOLAG also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Martin Orehag | Liquidator | 0 companies |
| Gunnie Eriksson | Deputy Board Member | 0 companies |
| Lars Jonas Eriksson | Board of Directors | 0 companies |